SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #2,816CAS 3区Top JournalReview JournalHybrid

Expert Opinion on Therapeutic Targets

Abbreviation (ISO):EXPERT OPIN. THER. TARGETS
Country: England•WoS SCIE Quartile: Q1•Scopus SJR: 1.383•SCImago Rank: #2,816•Identifier (ISSN):1472-8222(Print)/1744-7631(Online)•Articles / Year: 70•Estimated Publication Fee (APC): $3,550 USD
Clarivate IF (2026)Q1
5.1
↑ +0.7

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
78

78 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate2.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
70articles/year
11.48% Gold OA•14.49% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 5.1)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.1)
🔵 Computed
20252.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.4)
🔵 Computed
20242.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.6)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.8)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.797)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.902)
🔵 Computed
20203.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.473)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.621)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.598)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The journal evaluates molecules, signalling pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and early preclinical studies. Articles should not include clinical information including specific drugs and clinical trials. The Editors welcome: Reviews covering novel disease targets at the molecular level and information on early preclinical studies and their implications for future drug development. Articles should not include clinical information including specific drugs and clinical trials. Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs. The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.

Topics Covered (Recognized by AI)
Medicine97.5%Biology95.8%Internal medicine84.5%Genetics82.6%Chemistry80.3%Biochemistry77.7%Pathology43%Immunology40.3%Cancer research39.5%Cell biology39.5%Gene38.4%Psychology33.8%Bioinformatics32.5%Endocrinology31.9%Cancer31.6%Receptor29.9%Pharmacology24.8%Psychiatry21.9%Neuroscience21.6%Disease21.5%Physics20.2%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,816Scopus Q1SCImago Profile
Scopus Coverage:1997-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.383

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
120

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
4.52

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,550 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,322
3-Year Documents272
Citable Documents231

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Clinical BiochemistryQ1
Drug DiscoveryQ1
Molecular MedicineQ1
PharmacologyQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
2区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Taylor and Francis Ltd.
Publication Language
English
Frequency
Monthly
Founding Year
2001
Editorial Address
INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
PHARMACOLOGY & PHARMACY
JCRSCIE
65/356Q1
PHARMACOLOGY & PHARMACY
JCISCIE
127/356Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—7824
20254.474224
20244.686673
20235.81031,515
20226.797821,602
20216.902801,784
20205.4731104,267
20194.621783,574
20184.598915,139
2017—1075,319
2016—844,083
2015—1636,764
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Expert Opinion on Therapeutic Targets

WoS Q1
3568201820192020202120222023202420254.40
Annual Impact Factor Metric
2025:4.4

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: a49e7e5d-9e21-4c53-9785-8571fc45dd84
Database Updated: 2026-10-01